Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 37.10
+3.60 (10.75%)
Jun 11, 2026, 5:29 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 50.96 million as of June 11, 2026. Its market cap has increased by 231.25% in one year.
Market Cap
50.96M
Enterprise Value
49.67M
Revenue
20.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.10
Market Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 50.96M, a decrease of -55.20%. That is a compound annual growth rate of -9.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 50.96M | 271.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 99.60M |
| AcouSort AB | 95.87M |
| Scandinavian ChemoTech AB | 92.14M |
| Annexin Pharmaceuticals AB | 91.77M |
| Spago Nanomedical AB | 72.44M |
| Alzinova AB | 71.20M |
| Pila Pharma AB | 68.52M |
| Modus Therapeutics Holding AB | 58.50M |